Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective

被引:1
作者
Laspe, Insa
Meier, Juris J. [1 ,2 ,3 ]
Nauck, Michael A. [1 ,2 ,4 ]
机构
[1] Diabet Ctr Bad Lauterberg, Bad Lauterberg im Harz, Germany
[2] Ruhr Univ Bochum, St Josef Hosp, Katholisches Klinikum Bochum gGmbH, Dept Med 1,Diabetes,Endocrinol & Metab Sect, Bochum, Germany
[3] Augusta Hosp, Dept Internal Med, Bochum, Germany
[4] Ruhr Univ Bochum, St Josef Hosp, Katholisches Klinikum Bochum gGmbH, Dept Med 1,Endocrinol & Metab Sect, Gudrunstr 56, D-44791 Bochum, Germany
关键词
C-peptide; Diabetes mellitus; type; 1; 2; Diagnosis; differential; Insulin resistance; Latent auto-immune diabetes in adults; RESISTANCE;
D O I
10.4093/dmj.2021.0322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In clinical practice, the distinction between type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) can be challenging, leaving patients with "ambiguous" diabetes type. Insulin-treated patients (n=115) previously diagnosed with T2DM had to be re-classified based on clinical phenotype and laboratory results, and were operationally defined as having an ambiguous diabetes type. They were compared against patients with definite T1DM and T2DM regarding 12 clinical and laboratory features typically different between diabetes types. Characteristics of patients with ambiguous diabetes type, representing approximately 6% of all patients with T1DM or T2DM seen at our specialized clinic, fell in between those of patients with definite T1DM and T2DM, both regarding individual features and with respect to a novel classification based on multi-variable regression analysis (P< 0.0001). In conclusion, a substantial proportion of diabetes patients in a tertiary care centre presented with an "ambiguous" diabetes type. Their clinical characteristics fall in between those of definite T1DM or T2DM patients.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 20 条
[1]   Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables [J].
Ahlqvist, Emma ;
Storm, Petter ;
Karajamaki, Annemari ;
Martinell, Mats ;
Dorkhan, Mozhgan ;
Carlsson, Annelie ;
Vikman, Petter ;
Prasad, Rashmi B. ;
Aly, Dina Mansour ;
Almgren, Peter ;
Wessman, Ylva ;
Shaat, Nael ;
Spegel, Peter ;
Mulder, Hindrik ;
Lindholm, Eero ;
Melander, Olle ;
Hansson, Ola ;
Malmqvist, Ulf ;
Lernmark, Ake ;
Lahti, Kaj ;
Forsen, Tom ;
Tuomi, Tiinamaija ;
Rosengren, Anders H. ;
Groop, Leif .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05) :361-369
[2]  
Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc12-s064, 10.2337/dc13-S067, 10.2337/dc13-S011, 10.2337/dc10-S062, 10.2337/dc12-s011, 10.2337/dc10-S011]
[3]   Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 Diabetes [J].
Becht, F. S. ;
Walther, K. ;
Martin, E. ;
Nauck, M. A. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (03) :148-156
[4]  
Becker B, 2011, DIABETOL STOFFWECHS, V6, P202
[5]   OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN [J].
CHAN, JM ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC .
DIABETES CARE, 1994, 17 (09) :961-969
[6]   Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? [J].
Cleland, S. J. ;
Fisher, B. M. ;
Colhoun, H. M. ;
Sattar, N. ;
Petrie, J. R. .
DIABETOLOGIA, 2013, 56 (07) :1462-1470
[7]   Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms [J].
Corbin, Karen D. ;
Driscoll, Kimberly A. ;
Pratley, Richard E. ;
Smith, Steven R. ;
Maahs, David M. ;
Mayer-Davis, Elizabeth J. .
ENDOCRINE REVIEWS, 2018, 39 (05) :629-663
[8]  
DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313
[9]   From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].
DeFronzo, Ralph A. .
DIABETES, 2009, 58 (04) :773-795
[10]   Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes [J].
Donath, Marc Y. ;
Boeni-Schnetzler, Marianne ;
Ellingsgaard, Helga ;
Ehses, Jan A. .
PHYSIOLOGY, 2009, 24 (06) :325-331